share

(6,8-Dibromo-3-Ethyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid CAS NO 886500-99-8


Unit Price:

CAS No.:886500-99-8

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

(6,8-Dibromo-3-Ethyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid is a high-purity, advanced pharmaceutical intermediate characterized by its unique quinazolinone core structure. This compound is of significant commercial interest for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs) and fine chemicals. It is primarily sought by research institutions and manufacturers in the pharmaceutical, agrochemical, and specialty chemical industries for developing new therapeutic agents and high-value functional materials.

Application

  • Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of potential drug candidates, particularly those targeting specific enzymatic pathways.
  • Agrochemical Research: Used in the development of new herbicides, fungicides, or pesticides, leveraging its heterocyclic structure for bioactivity.
  • Chemical Synthesis Building Block: Employed in organic synthesis for constructing complex quinazolinone derivatives for material science and catalysis research.
  • Biochemical Probe Development: Utilized in life sciences research to create molecular probes for studying biological processes and target validation.
  • Fine Chemical Production: Acts as a specialized intermediate in the manufacture of dyes, pigments, or other performance chemicals.

Basic Information

Item Details
Product Name (6,8-Dibromo-3-Ethyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid
CAS No. 886500-99-8
Molecular Formula C₁₂H₁₀Br₂N₂O₃S
Molecular Weight 422.09 g/mol
Synonyms 2-[(6,8-Dibromo-3-ethyl-4-oxo-3,4-dihydroquinazolin-2-yl)thio]acetic acid; (6,8-Dibromo-3-ethyl-4-oxo-3,4-dihydro-2-quinazolinylthio)acetic Acid; Quinazolin-2-ylthioacetic acid derivative; DBEOQA; CAS 886500-99-8
EINECS Contact for details

Quality Control

Our (6,8-Dibromo-3-Ethyl-4-Oxo-3,4-Dihydro-Quinazolin-2-Ylsulfanyl)-Acetic Acid is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing to ensure high purity and consistency, meeting the stringent requirements for pharmaceutical intermediate applications. Comprehensive Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item Specification
Appearance White to off-white crystalline powder
Identification (IR) Conforms to structure
Purity (HPLC) ≥ 98.0%
Loss on Drying ≤ 1.0%
Residue on Ignition ≤ 0.1%
Heavy Metals ≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.